We are investigating the production records.This case was reported from a physician.The lot number of artz dispo was 5l3c08.The patient was transported urgently and we couldn't investigate because information on transported hospital was not obtained.According to the reporting physician, the injection technique was no problem, because there were no problems for the first and second injections.The physician disinfected the knee with isodine and wore gloves.The physician instructed him to rest and take no bathing.It was considered that infection accidentally happened, and septic arthritis was highly probably related to artz dispo.Company comment: all of product batches passed with the release test including the sterility test before the product release.It is therefore highly unlikely that the product quality was related to the infection.The manufacturer's causality assessment is determined as "not related".
|
This is a definitive report.We corrected h.6 adverse event problem of fda investigation findings from 3221 to 213, and fda investigation conclusions from 11 to 67.We had the result of investigations for no.5l3c08 and changed company comment below.According to the reporting physician, the injection technique was no problem, because there were no problems for the first and second injections.The physician disinfected the knee with isodine and wore gloves.The physician instructed him to rest and take no bathing.It was considered that infection accidentally happened, and septic arthritis was highly probably related to artz dispo.Company comment: according to the result of investigations, there were no deviations or out-of-specifications found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring for lot no.5l3c08.Manufacturer's causality assessment is determined as "not related".
|